MCP1 haplotypes associated with protection from pulmonary tuberculosis

BMC Genetics

Volumn 12, Issue , 2011, Pages

  Intemann, Christopher D ^a,b   Thye, Thorsten ^a,b   Förster, Birgit ^a   Owusu Dabo, Ellis ^c,d   Gyapong, John ^e   Horstmann, Rolf D ^a   Meyer, Christian G ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

^d KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^e UNIVERSITY OF GHANA   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ALLELE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE RESISTANCE; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GHANA; HAPLOTYPE; HUMAN; INTRON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MCP1 GENE; REPORTER GENE; CASE CONTROL STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; PHYSIOLOGY;

CASE-CONTROL STUDIES; CHEMOKINE CCL2; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GHANA; HAPLOTYPES; HUMANS; IMMUNITY, INNATE; LINKAGE DISEQUILIBRIUM; SEQUENCE DELETION; TUBERCULOSIS, PULMONARY;

EID: 79955098196     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/1471-2156-12-34     Document Type: Article

References (26)

1. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994, 91:3652-3656. 10.1073/pnas.91.9.3652, 43639, 8170963.
2. Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008, 26:421-452. 10.1146/annurev.immunol.26.021607.090326, 2921669, 18303997.
3. Lin Y, Gong J, Zhang M, Xue W, Barnes PF. Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect Immun 1998, 66:2319-2322. 108197, 9573123.
4. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, Montaño M, Barnes PF, Selman M, Granados J. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 2005, 202:1649-1658. 10.1084/jem.20050126, 2212957, 16352737.
5. Katoh S, Matsumoto N, Fukushima K, Mukae H, Kadota JI, Kohno S, Matsukura S. Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. J Allergy Clin Immunol 2000, 106:730-736. 10.1067/mai.2000.109827, 11031344.
6. Ganachari M, Ruiz-Morales JA, Gomez de la Torre Pretell JC, Dinh J, Granados J, Flores-Villanueva PO. Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals. PLoS One 2010, 5:e8881. 10.1371/journal.pone.0008881, 2810343, 20111728.
7. Buijtels PC, van de Sande WW, Parkinson S, Petit PL, van der Sande MA, van Soolingen D, Verbrugh HA, van Belkum A. Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia. Int J Tuberc Lung Dis 2008, 12:1485-1488.
8. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999, 259:344-348. 10.1006/bbrc.1999.0796, 10362511.
9. Park HJ, Yoon SH, Zheng LT, Lee KH, Kim JW, Chung JH, Lee YA, Hong SJ. Association of the -2510A/G chemokine (C-C motif) ligand 2 polymorphism with knee osteoarthritis in a Korean population. Scand J Rheumatol 2007, 36:299-306. 10.1080/03009740701288165, 17763208.
10. Brown KS, Nackos E, Morthala S, Jensen LE, Whitehead AS, Von Feldt JM. Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus. J Rheumatol 2007, 34:740-746.
11. Kouyama K, Miyake K, Zenibayashi M, Hirota Y, Teranishi T, Tamori Y, Kanda H, Sakaguchi K, Ohara T, Kasuga M. Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes. Kobe J Med Sci 2008, 53:345-354.
12. Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ, Howson JM, Shaw MA, Burgner D, Xu W, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM. Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 2004, 5:46-57. 10.1038/sj.gene.6364029, 14735149.
13. Chu SF, Tam CM, Wong HS, Kam KM, Lau YL, Chiang AK. Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes Immun 2007, 8:475-479. 10.1038/sj.gene.6364412, 17625600.
14. Thye T, Nejentsev S, Intemann CD, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, Zeitels LR, Herb F, Horstmann RD, Meyer CG. MCP-1 promoter variant s-362C associated with protection from pulmonary tuberculosis in Ghana, West Africa. Hum Mol Genet 2009, 18:381-388. 2638774, 18940815.
15. Möller M, Nebel A, Valentonyte R, van Helden PD, Schreiber S, Hoal EG. Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population. Tuberculosis (Edinb) 2009, 89:189-194.
16. Nyquist P, Zhang J, De Graba TJ. The -928 G/C and -362 G/C single-nucleotide polymorphisms in the promoter of MCP-1: Increased transcriptional activity and novel binding sites. Cerebrovasc Dis 2010, 29:242-247. 10.1159/000267849, 20029197.
17. Holm S. A Simple Sequentially Rejective Bonferroni Test Procedure. Scand J Statistics 1979, 6:65-70.
18. Juneau K, Miranda M, Hillenmeyer ME, Nislow C, Davis RW. Introns regulate RNA and protein abundance in yeast. Genetics 2006, 174:511-518. 10.1534/genetics.106.058560, 1569799, 16816425.
19. Rahkonen O, Su M, Hakovirta H, Koskivirta I, Hormuzdi SG, Vuorio E, Bornstein P, Penttinen R. Mice with a deletion in the first intron of the Col1a1 gene develop age-dependent aortic dissection and rupture. Circ Res 2004, 94:83-90. 10.1161/01.RES.0000108263.74520.15, 14630726.
20. Ghogawala Z, Choi E, Daly KR, Blanco LR, Griffith IJ, Glimcher LH. An intronic 10-base-pair deletion in a class II A beta gene affects RNA processing. Mol Cell Biol 1989, 9:4402-4408. 362522, 2555693.
21. Kurachi S, Hitomi Y, Furukawa M, Kurachi K. Role of intron I in expression of the human factor IX gene. J Biol Chem 1995, 270:5276-5281. 10.1074/jbc.270.10.5276, 7890639.
22. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 1995, 155:4838-4843.
23. Kipnis A, Basaraba RJ, Orme IM, Cooper AM. Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis. Immunology 2003, 109:547-551. 10.1046/j.1365-2567.2003.01680.x, 1783002, 12871221.
24. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998, 187:601-608. 10.1084/jem.187.4.601, 2212142, 9463410.
25. Schreiber O, Steinwede K, Ding N, Srivastava M, Maus R, Länger F, Prokein J, Ehlers S, Welte T, Gunn MD, Maus UA. Mice that overexpress CC chemokine ligand 2 in their lungs show increased protective immunity to infection with Mycobacterium bovis bacille Calmette-Guérin. J Infect Dis 2008, 198:1044-1054. 10.1086/591501, 18694332.
26. Thye T, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, Niemann S, Rüsch-Gerdes S, Horstmann RD, Meyer CG. No associations of human pulmonary tuberculosis with Sp110 variants. J Med Genet 2006, 43:e32. 2564561, 16816019.